These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Fatal agranulocytosis induced by aprindine]. García Saavedra V; Peró Silva A; Llorente A; Richart C Rev Clin Esp; 1989; 185(3):169. PubMed ID: 2623233 [No Abstract] [Full Text] [Related]
7. [Agranulocytosis during use of aprindine]. van Leeuwen R Ned Tijdschr Geneeskd; 1976 Sep; 120(36):1549-50. PubMed ID: 967294 [No Abstract] [Full Text] [Related]
8. [Agranulocytosis caused by aprindine. Apropos of a new case]. González Juanatey JR; Amaro Cendon A; Pose Reino A; Torre Carballada A; Rubio Alvarez J; Gil de la Peña M Med Clin (Barc); 1984 May; 82(19):865-6. PubMed ID: 6738221 [No Abstract] [Full Text] [Related]
11. [Agranulocytosis and aprindine]. Rouveix B; Lassoued K; Abel L; Regnier B Therapie; 1986; 41(6):517-8. PubMed ID: 3810547 [No Abstract] [Full Text] [Related]
12. [Agranulocytosis after use of aprindine (Fiboran)]. Poortermans JC; Majid PA; Roos JP Ned Tijdschr Geneeskd; 1976 Nov; 120(46):2011-2. PubMed ID: 1012364 [No Abstract] [Full Text] [Related]
13. [Fatal course of agranulocytosis during antiarryhthmic aprindine therapy]. Hausamen TU; Weber FW Dtsch Med Wochenschr; 1977 Oct; 102(42):1523-4. PubMed ID: 913289 [No Abstract] [Full Text] [Related]
14. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448 [TBL] [Abstract][Full Text] [Related]
15. [Agranulocytosis after treatment with apridine]. Baedeker W; Rastetter J MMW Munch Med Wochenschr; 1977 Aug; 119(32-33):1047-8. PubMed ID: 408649 [No Abstract] [Full Text] [Related]
16. Relevance of in vitro studies of drug-induced agranulocytosis. Report of 14 cases. Parent-Massin DM; Sensébé L; Léglise MC; Guern G; Berthou C; Riché C; Abgrall JF Drug Saf; 1993 Dec; 9(6):463-9. PubMed ID: 8129866 [TBL] [Abstract][Full Text] [Related]
17. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes. Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354 [TBL] [Abstract][Full Text] [Related]
18. Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach. Ibáñez L; Juan J; Pérez E; Carné X; Laporte JR Eur Heart J; 1991 May; 12(5):639-41. PubMed ID: 1874265 [TBL] [Abstract][Full Text] [Related]
19. Quinidine-induced neutropenia: report of a case with drug-dependent inhibition of granulocyte colony generation. Ascensao JL; Flynn PJ; Slungaard A; Wachsman W; Zanjani ED; Jacob HS Acta Haematol; 1984; 72(5):349-54. PubMed ID: 6441417 [TBL] [Abstract][Full Text] [Related]
20. Effect of 2 anti-arrhythmic drugs aprindine and moxaprindine on the replication capacity of murine and human haemopoietic cells. Stryckmans PA; Ronge-Collard E; Delforge A; Lambert M; Suciu S Scand J Haematol; 1982 Oct; 29(4):331-7. PubMed ID: 7178839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]